-
Global Market Report on Anticoccidial Drugs 2025: Business Expansion, Influencing Factors, and Trends Through 2029
24 Dec 2025 15:00 GMT
… important veterinary pharmaceutical segment.
Anticoccidial Drugs Market Size … products, advances in drug delivery methods, … Drugs and Their Role
Anticoccidial drugs are medications designed … 47;report/bladder-cancer-drugs-global-market-report
…
-
<![CDATA[Ilaha Isali, MD, MSc, discusses sex-specific tumor and immune features in bladder cancer]]>
23 Dec 2025 17:08 GMT
… in bladder cancer research and in the design of clinical trials.
One … have sex-specific relevance in bladder cancer progression. Differences in immune … disease progression, and treatment response, particularly in female bladder cancer patients.
REFERENCE
1 …
-
SMH participates in global bladder cancer treatment clinical trial
21 Dec 2025 11:13 GMT
… trials investigating potential non-surgical options for patients with early-stage bladder cancer … not respond to current treatments. To help identify … ABLE-32 trials, sponsored by Ferring Pharmaceuticals.
Dr. … with NMIBC. The treatment uses a non-replicating …
-
J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant (Revised)
23 Dec 2025 11:53 GMT
… pill remained a major advantage over the IV-administered Rybrevant.
The FDA … multiple myeloma treatment Darzalex and prostate cancer drug Erleada.
New cancer drugs, such … high-risk non-muscle invasive bladder cancer and the subcutaneous formulation of …
-
<![CDATA[The Targeted Pulse: FDA Decisions and Trial Updates]]>
21 Dec 2025 14:04 GMT
… week, we saw groundbreaking FDA decisions across multiple cancer … patients with muscle-invasive bladder cancer. This marks the first … Metastatic Colorectal Cancer
The FDA has granted fast … treatment-related adverse events). A registrational phase 3 trial …
-
Novo files for CagriSema approval; Merck and Pfizer’s trial win
19 Dec 2025 20:18 GMT
… is focused on antisense oligonucleotide drugs that boost gene expression, … #47;Astellas antibody-drug conjugate Padcev succeeded in another bladder cancer study, helping … companies said Wednesday. Trial enrollees had muscle-invasive bladder cancer that hadn’t …
-
Fierce Pharma Asia—Daiichi ADCs' 1st-line nod, trial deaths; Takeda's TYK2 trial win
19 Dec 2025 18:29 GMT
… first new first-line treatment of HER2-positive metastatic … psoriasis. The drug beat placebo on the trials’ co-primary … controversial Alzheimer's med
Fosun Pharma is spending about $ … another patient survival benefit in bladder cancer
10. Yarrow blooms with …
-
Genital Dysfunction Drugs Market is expected to reach US$ 7.16 billion by 2031 | DataM Intelligence
19 Dec 2025 09:32 GMT
… treatments.
Segmentation by gender application shows that drugs … drug manufacturing for genital damage treatment also present new innovation pathways. Additionally, pharmaceutical … updates noted FDA approvals for … combinations for bladder cancer, indirectly …
-
A Grading System of Intratumoral Tertiary Lymphoid Structure for Combined Hepatocellular-Cholangiocarcinoma: A Multicenter Pathological Study
24 Dec 2025 22:48 GMT
… morphological information to optimize treatment selection.
The success of … for future immunotherapy clinical trials.
However, there are … cholangiocarcinoma after resection. Cancer Med. 2019;8(13):5862 … and poor prognosis in bladder cancer. DNA Cell Biol. …
-
Pat Finn, Chicago comedic actor who was close pals with Chris Farley, dies at 60
24 Dec 2025 22:35 GMT
… a three-year battle with bladder cancer in Los Angeles. He was … Done Watching the O.J. Trial.”
In 1994, at age 29 … Done Watching the O.J. Trial” when the director of the … ” in 1995, died from a drug overdose Dec. 18, 1997, in …